in situ Hi-C profiles of DP thymocyltes from control and Suv39h1/Suv39h2 double knockout mice

RNA-seq, LaminB1 ChIP-seq and in situ Hi-C of double positive thymocytes from control and Suv39h1/Suv39h2 double knockout mice

Enhancer infestation drives tumorigenic activation of inactive compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma [4C-Seq]

Enhancer infestation drives tumorigenic activation of inactive compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma [Hi-C]

Enhancer infestation drives tumorigenic activation of inactive compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma

Study of the eIFG1-eIF1 interaction by TCP-seq on translation initiation in HEK 293T cells

Non-canonical RNA substrates of Drosha lack many of the conserved features found in primary microRNA stem-loops

Early-Onset Hearing Loss in Mouse Models of Alzheimer’s Disease correlates to DNA Damage in Cochlea

Concurrent profiling of multiscale 3D genome organization and gene expression in single mammalian cells

BRCA2 suppresses “head-on” transcription-replication conflicts incurred by dormant origin firing at transcription termination sites

Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals I

Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals II

Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals

Spatiotemporal immune atlas of a clinical-grade gene-edited pig-to-human kidney xenotransplant

Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions [Hi-C]

Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions

Study of the translation initiation by Selective TCP-seq in the context of eIF1-eIF4G1 inhibitor